BioCentury
ARTICLE | Clinical News

Recombinant IL-7 regulatory update

October 29, 2012 7:00 AM UTC

Cytheris said FDA granted Orphan Drug designation for CYT107 to treat progressive multifocal leukoencephalopathy (PML). The company plans to begin a pivotal Phase IIb trial of CYT107 to treat HIV-rela...